Controlling cGMP production in light-sensing retinal cells
Regulation of Cyclic GMP Synthesis in Photoreceptors
This project looks at how proteins control production of cGMP in rod and cone cells to help people with inherited forms of RetGC-related blindness get better treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11184477 on NIH RePORTER |
What this research studies
From my perspective, researchers are working to understand how retinal guanylyl cyclase (RetGC) makes cGMP and how regulatory proteins (GCAPs and RD3) interact with it. They use biochemical experiments, structural mapping, and genetic analyses to identify mutations and interaction interfaces that disrupt normal function. The team connects these molecular findings to inherited forms of congenital blindness and uses that knowledge to guide therapeutic approaches. This work builds on earlier discoveries that have already led to initial clinical trials for RetGC-linked vision loss.
Who could benefit from this research
Good fit: People with inherited retinal degeneration caused by mutations affecting retinal guanylyl cyclase (for example GUCY2D), GCAPs, or RD3, or those interested in future related clinical trials, would be the most relevant candidates.
Not a fit: People with vision loss from non-genetic causes, unrelated retinal conditions, or very advanced photoreceptor loss may not directly benefit from this research.
Why it matters
Potential benefit: Could lead to new gene- or molecule-based therapies that preserve or restore vision for people with RetGC-related inherited retinal disease.
How similar studies have performed: Related molecular studies of RetGC regulation have already supported early clinical trials for RetGC-linked blindness, so there is promising precedent though important molecular details are still being clarified.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Dizhoor, Alexander M — Drexel University
- Study coordinator: Dizhoor, Alexander M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.